Literature DB >> 29306505

IgG antibody prevalence suggests high immunization needs in newcomers to Luxembourg, 2012.

Judith M Hübschen1, Emilie Charpentier2, Pierre Weicherding3, Claude P Muller4.   

Abstract

Vaccine coverage of the general population in Luxembourg is high, but refugees or asylum seekers may be incompletely vaccinated and susceptible to vaccine-preventable diseases. In order to assess protection rates, serum and oral fluid samples were collected from 406 newcomers aged between 13 and 70 years arriving between May and September 2012. Sera were screened for IgG antibodies against measles, rubella, mumps, hepatitis B, tetanus, diphtheria and pertussis. Oral fluid samples were screened for antibodies against measles, mumps and rubella virus to investigate their suitability for antibody prevalence studies. More than 90% of the participants had IgG antibodies against rubella, 73% against measles and 56% against mumps. Less than 19% had anti-HBs antibodies. Nearly 84% of the participants had an adequate protection against tetanus, 73% against diphtheria and 40% had pertussis antibodies. 93%, 95% and 78% of the measles, rubella and mumps test results obtained with serum and oral fluid were concordant. The majority of the participants lacked antibodies against at least one of the measles/mumps/rubella (58%) and diphtheria/tetanus/pertussis (72%) vaccine components and against hepatitis B virus (82%) and might thus profit from vaccination. Oral fluid is a suitable alternative and non-invasive specimen for measles/rubella antibody prevalence studies.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diphtheria-tetanus-pertussis vaccine; Hepatitis B; Hepatitis C; Measles-mumps-rubella vaccine; Vaccine-preventable diseases

Mesh:

Substances:

Year:  2018        PMID: 29306505     DOI: 10.1016/j.vaccine.2017.12.041

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Inequalities in vaccination coverage and differences in follow-up procedures for asylum-seeking children arriving in Wales, UK.

Authors:  Malorie Perry; Molly Townson; Simon Cottrell; Lucy Fagan; Jonathan Edwards; Jean Saunders; Roisin O'Hare; Gill Richardson
Journal:  Eur J Pediatr       Date:  2019-11-07       Impact factor: 3.183

2.  Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.

Authors:  Í Ödemiş; Ş Köse; Í Akbulut; H Albayrak
Journal:  Rev Esp Quimioter       Date:  2019-10-23       Impact factor: 1.553

3.  Asylum seekers' perspectives on vaccination and screening policies after their arrival in Greece and The Netherlands.

Authors:  Christina Louka; Elizabeth Chandler; Adelita V Ranchor; Hans Broer; Spyros Pournaras; Sofanne J Ravensbergen; Ymkje Stienstra
Journal:  PLoS One       Date:  2019-12-26       Impact factor: 3.240

4.  Interventions to Improve Vaccination Uptake and Cost Effectiveness of Vaccination Strategies in Newly Arrived Migrants in the EU/EEA: A Systematic Review.

Authors:  Charles Hui; Jessica Dunn; Rachael Morton; Lukas P Staub; Anh Tran; Sally Hargreaves; Christina Greenaway; Beverly Ann Biggs; Robin Christensen; Kevin Pottie
Journal:  Int J Environ Res Public Health       Date:  2018-09-20       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.